Amedisys Inc
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services,… Read more
Market Cap & Net Worth: Amedisys Inc (AMED)
Amedisys Inc (NASDAQ:AMED) has a market capitalization of $3.32 Billion ($3.32 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3748 globally and #2415 in its home market, demonstrating a 1.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amedisys Inc's stock price $100.99 by its total outstanding shares 32887700 (32.89 Million).
Amedisys Inc Market Cap History: 2015 to 2025
Amedisys Inc's market capitalization history from 2015 to 2025. Data shows growth from $1.29 Billion to $3.32 Billion (9.63% CAGR).
Index Memberships
Amedisys Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.15% | #90 of 976 |
|
NASDAQ Composite
IXIC
|
$33.26 Trillion | 0.01% | #461 of 3165 |
|
S&P Midcap 400
MID
|
$3.04 Trillion | 0.12% | #330 of 401 |
Weight: Amedisys Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Amedisys Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amedisys Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.27x
Amedisys Inc's market cap is 1.27 times its annual revenue
0.38x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
69.07x
Amedisys Inc's market cap is 69.07 times its annual earnings
6.33x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.29 Billion | $1.28 Billion | -$3.02 Million | 1.01x | N/A |
| 2016 | $1.40 Billion | $1.44 Billion | $37.26 Million | 0.98x | 37.63x |
| 2017 | $1.73 Billion | $1.53 Billion | $30.30 Million | 1.13x | 57.21x |
| 2018 | $3.85 Billion | $1.66 Billion | $119.35 Million | 2.32x | 32.27x |
| 2019 | $5.49 Billion | $1.96 Billion | $126.83 Million | 2.81x | 43.28x |
| 2020 | $9.65 Billion | $2.07 Billion | $183.61 Million | 4.66x | 52.54x |
| 2021 | $5.32 Billion | $2.21 Billion | $209.07 Million | 2.40x | 25.46x |
| 2022 | $2.75 Billion | $2.22 Billion | $118.61 Million | 1.24x | 23.16x |
| 2023 | $3.13 Billion | $2.24 Billion | -$9.75 Million | 1.40x | N/A |
| 2024 | $2.99 Billion | $2.35 Billion | $43.23 Million | 1.27x | 69.07x |
Competitor Companies of AMED by Market Capitalization
Companies near Amedisys Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Amedisys Inc by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #257 globally with a market cap of $79.40 Billion USD.
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1029 globally with a market cap of $18.98 Billion USD.
- Fresenius SE & Co. KGaA (PINK:FSNUF): Ranked #1139 globally with a market cap of $16.86 Billion USD.
- Brookdale Senior Living Inc (NYSE:BKDT): Ranked #1223 globally with a market cap of $15.19 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #257 | HCA Holdings Inc | NYSE:HCA | $79.40 Billion | $525.19 |
| #1029 | Tenet Healthcare Corporation | NYSE:THC | $18.98 Billion | $219.30 |
| #1139 | Fresenius SE & Co. KGaA | PINK:FSNUF | $16.86 Billion | $41.01 |
| #1223 | Brookdale Senior Living Inc | NYSE:BKDT | $15.19 Billion | $77.60 |
Amedisys Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Amedisys Inc's market cap moved from $1.29 Billion to $ 3.32 Billion, with a yearly change of 9.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.32 Billion | +11.23% |
| 2024 | $2.99 Billion | -4.49% |
| 2023 | $3.13 Billion | +13.79% |
| 2022 | $2.75 Billion | -48.39% |
| 2021 | $5.32 Billion | -44.81% |
| 2020 | $9.65 Billion | +75.73% |
| 2019 | $5.49 Billion | +42.53% |
| 2018 | $3.85 Billion | +122.18% |
| 2017 | $1.73 Billion | +23.65% |
| 2016 | $1.40 Billion | +8.42% |
| 2015 | $1.29 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Amedisys Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.32 Billion USD |
| MoneyControl | $3.32 Billion USD |
| MarketWatch | $3.32 Billion USD |
| marketcap.company | $3.32 Billion USD |
| Reuters | $3.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.